Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (13949)	7/4/2000 4:24:59 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Cacaito, please, let us stay on task. One more time I AM NOT INTERESTED IN ANYTHING BUT SIGNIFICANT REDUCTION OF BACTEREMIA SECONDARY TO GRAM NEG INFECTION!!!!!!!!!! I am getting so tired of stating that!!!!!! Now as you know only qualification for Hemo Trama trial was needing 2 pints of blood. There was no measuring of BACTEREMIA secondary to GRAM NEG INFECTION!!!!!!!!! Show me where Chiron has SIGNIFICANTLY REDUCED BACTEREMIA SECONDARY TO GRAM NEG INFECTION!!!!!!!!